Change in FeNO with dupilumab and tezepelumab in severe eosinophilic asthma

被引：0
|
作者：
Gates, J. [1 ]
Hearn, A. [1 ]
Maynard-Paquette, A. C. [1 ]
Green, L. [1 ]
Thomson, L. [1 ]
Fernandes, M. [1 ]
Roxas, C. [1 ]
Lam, J. [1 ]
d'Ancona, G. [1 ]
Dhariwal, J. [1 ]
Nanzer, A. M. [1 ]
Jackson, D. J. [1 ]
机构：
[1] Guys & St Thomas NHS Trust, Guys Severe Asthma Ctr, London, England
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.411
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
M22
引用
收藏
页码：A274 / A274
页数：1
相关论文
共 50 条
  • [1] Dupilumab and tezepelumab in severe refractory asthma: new opportunities
    Ragnoli, Beatrice
    Morjaria, Jaymin
    Pignatti, Patrizia
    Montuschi, Paolo
    Barbieri, Mariangela
    Mondini, Lucrezia
    Ruggero, Luca
    Trotta, Liliana
    Malerba, Mario
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [2] Indirect comparison of dupilumab versus tezepelumab in patients with severe asthma
    Chapman, Kenneth R.
    Guyot, Patricia
    Bourhis, Francois
    Msihid, Jerome
    Nair, Radhika
    Nag, Arpita
    Hardin, Megan
    Jacob-Nara, Juby
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 560 - 560
  • [3] Relationship between FeNO suppression and Clinical Remission with Tezepelumab in Severe Asthma
    Gates, Jessica
    Haris, Faizan
    Green, Linda
    Lam, Jodie
    Fernandes, Mariana
    Thomson, Louise
    Roxas, Cris
    D'Ancona, Grainne
    Dhariwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
    Yoni E. van Dijk
    Niels W. Rutjes
    Korneliusz Golebski
    Havva Şahin
    Simone Hashimoto
    Anke-Hilse Maitland-van der Zee
    Susanne J. H. Vijverberg
    Pediatric Drugs, 2023, 25 : 677 - 693
  • [5] Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
    van Dijk, Yoni E.
    Rutjes, Niels W.
    Golebski, Korneliusz
    Sahin, Havva
    Hashimoto, Simone
    Van der Zee, Anke-Hilse
    Vijverberg, Susanne J. H.
    PEDIATRIC DRUGS, 2023, 25 (06) : 677 - 693
  • [6] Effectiveness of dupilumab on lung function in severe eosinophilic asthma
    Simoes, Joana Filipe Marques
    Silva, Raquel
    Lopes, Carlos
    Cabrita, Henrique
    Manique, Alda
    Barbara, Cristina
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] The impact of treatment with omalizumab, mepolizumab, benralizumab, dupilumab and tezepelumab in patients with severe asthma
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Kuwano, Kazuyoshi
    Umeda, Akira
    To, Yasuo
    RESPIROLOGY, 2023, 28 : 339 - 340
  • [8] The impact of treatment with omalizumab, mepolizumab, benralizumab, dupilumab and tezepelumab in patients with severe asthma
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Kuwano, Kazuyoshi
    Umeda, Akira
    To, Yasuo
    Sakao, Seiichiro
    RESPIROLOGY, 2024, 29 : 97 - 98
  • [9] Tezepelumab in patients with allergic and eosinophilic asthma
    Caminati, Marco
    Buhl, Roland
    Corren, Jonathan
    Hanania, Nicola A.
    Kim, Harold
    Korn, Stephanie
    Lommatzsch, Marek
    Martin, Neil
    Matucci, Andrea
    Nasser, Shuaib M.
    Pavord, Ian D.
    Domingo, Christian
    ALLERGY, 2024, 79 (05) : 1134 - 1145
  • [10] Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma
    Masumoto, Nami
    Oshikata, Chiyako
    Nakadegawa, Ryo
    Motobayashi, Yuto
    Osada, Reeko
    Manabe, Saki
    Kaneko, Takeshi
    Tsurikisawa, Naomi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (04): : 857 - 865
12345